What You Should Know:
– B. Braun Medical Inc. (B. Braun), a provider of infusion therapy and pain management, unveiled Peripheral Advantage, a new program that is designed to improve patients’ experience with peripheral intravenous (IV) therapy.
– The comprehensive program combines clinical instruction, data-driven insights and advanced tools to empower nurses to achieve first-stick success and help prevent many of the complications associated with peripheral IV therapy.
– Peripheral Advantage, which is now available to all hospitals nationwide, addresses a long tolerated, yet unacceptable reality: Although vascular access is the most common invasive procedure, most nurses are not provided with the training, techniques or tools they need to achieve first-stick success.
Share this article
BETHLEHEM, Pa., April 29, 2021 /PRNewswire/
B. Braun Medical Inc. (B. Braun), a leader in infusion therapy and pain management, today unveiled Peripheral Advantage
®, a new program that is designed to improve patients experience with peripheral intravenous (IV) therapy. The comprehensive program combines clinical instruction, data-driven insights and advanced tools to empower nurses to achieve first-stick success and help prevent many of the complications associated with peripheral IV therapy.
Peripheral Advantage, which is now available to all hospitals nationwide, addresses a long tolerated, yet unacceptable reality: Although vascular access is the most common invasive procedure, most nurses are not provided with the training, techniques or tools they need to achieve first-stick success. Only 57% or less of nursing students receive any form of Peripheral Intravenous Catheter (PIVC) training.
The Need for Better Training for IV Insertions healthleadersmedia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healthleadersmedia.com Daily Mail and Mail on Sunday newspapers.